Related Experiment Video

Updated: Jul 14, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Carvedilol therapy is associated with an improvement in left atrial appendage function in patients with congestive

Serdar Sevimli1, Mustafa Yilmaz, Fuat Gundogdu

  • 1Department of Cardiology, Medical School Hospital, Ataturk University, Erzurum, Turkey. drserdarsevimli@hotmail.com

Echocardiography (Mount Kisco, N.Y.)
|June 23, 2007
PubMed

Insights

Carvedilol therapy significantly improved left atrial appendage function in patients with heart failure. This treatment enhanced key metrics like LAA empty velocity and area change, offering a potential benefit for cardiac health.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Heart failure is a major global cause of mortality.
  • The left atrial appendage (LAA) plays a crucial role in cardiac function.
  • Understanding interventions that improve cardiac function in heart failure is vital.

Purpose of the Study:

  • To investigate the impact of carvedilol therapy on left atrial appendage (LAA) function in patients with symptomatic congestive heart failure.
  • To assess changes in LAA area change (LAAAC), LAA empty velocity (LAAEV), and LAA empty velocity time integral (LAAEVTI) following carvedilol treatment.

Main Methods:

  • Twenty patients with symptomatic congestive heart failure (ejection fraction ≤ 40%) were enrolled.
  • Carvedilol dosage was titrated over 8 weeks.
  • Transesophageal echocardiography was used to measure LAA function before and after treatment (at 3 months).

Main Results:

  • Carvedilol therapy significantly reduced heart rate and systolic blood pressure.
  • A significant increase was observed in LAA empty velocity (LAAEV), LAA empty velocity time integral (LAAEVTI), and LAA area change (LAAAC).

Conclusions:

  • Carvedilol therapy is associated with improved left atrial appendage function in patients suffering from symptomatic congestive heart failure.
  • These findings suggest a potential therapeutic benefit of carvedilol in enhancing cardiac function through LAA improvement.

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...